Literature DB >> 12771939

Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.

Ann Dekoninck1, Claire Calomme, Séverine Nizet, Yvan de Launoit, Arsène Burny, Jacques Ghysdael, Carine Van Lint.   

Abstract

Bovine leukemia virus (BLV) is a B-lymphotropic oncogenic retrovirus whose transcriptional promoter is located in the viral 5' long terminal repeat (LTR). To date, no B-lymphocyte-specific cis-regulatory element has been identified in this region. Since ETS proteins are known to regulate transcription of numerous retroviruses, we searched for the presence in the BLV promoter region of binding sites for PU.1/Spi-1, a B-cell- and macrophage-specific ETS family member. In this report, nucleotide sequence analysis of the viral LTR identified a PUbox located at -95/-84 bp. We demonstrated by gel shift and supershift assays that PU.1 and the related Ets transcription factor Spi-B interacted specifically with this PUbox. A 2-bp mutation (GGAA-->CCAA) within this motif abrogated PU.1/Spi-B binding. This mutation caused a marked decrease in LTR-driven basal gene expression in transient transfection assays of B-lymphoid cell lines, but did not impair the responsiveness of the BLV promoter to the virus-encoded transactivator Tax(BLV). Moreover, ectopically expressed PU.1 and Spi-B proteins transactivated the BLV promoter in a PUbox-dependent manner. Taken together, our results provide the first demonstration of regulation of the BLV promoter by two B-cell-specific Ets transcription factors, PU.1 and Spi-B. The PU.1/Spi-B binding site identified here could play an important role in BLV replication and B-lymphoid tropism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771939     DOI: 10.1038/sj.onc.1206392

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.

Authors:  Leslie J Marshall; Lisa D Moore; Matthew M Mirsky; Eugene O Major
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

2.  Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency.

Authors:  Claire Calomme; Ann Dekoninck; Séverine Nizet; Emmanuelle Adam; Thi Liên-Anh Nguyên; Anne Van Den Broeke; Luc Willems; Richard Kettmann; Arsène Burny; Carine Van Lint
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcription factor binding.

Authors:  Valérie Pierard; Allan Guiguen; Laurence Colin; Gaëlle Wijmeersch; Caroline Vanhulle; Benoît Van Driessche; Ann Dekoninck; Jana Blazkova; Christelle Cardona; Makram Merimi; Valérie Vierendeel; Claire Calomme; Thi Liên-Anh Nguyên; Michèle Nuttinck; Jean-Claude Twizere; Richard Kettmann; Daniel Portetelle; Arsène Burny; Ivan Hirsch; Olivier Rohr; Carine Van Lint
Journal:  J Biol Chem       Date:  2010-04-22       Impact factor: 5.157

4.  Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity.

Authors:  Leslie J Marshall; Lisa Dunham; Eugene O Major
Journal:  J Gen Virol       Date:  2010-09-08       Impact factor: 3.891

5.  Chromatin disruption in the promoter of bovine leukemia virus during transcriptional activation.

Authors:  Laurence Colin; Ann Dekoninck; Michal Reichert; Miriam Calao; Makram Merimi; Anne Van den Broeke; Valérie Vierendeel; Yvette Cleuter; Arsène Burny; Olivier Rohr; Carine Van Lint
Journal:  Nucleic Acids Res       Date:  2011-09-02       Impact factor: 16.971

6.  Comprehensive genome-wide transcription factor analysis reveals that a combination of high affinity and low affinity DNA binding is needed for human gene regulation.

Authors:  Junbai Wang; Agnieszka Malecka; Gunhild Trøen; Jan Delabie
Journal:  BMC Genomics       Date:  2015-06-11       Impact factor: 3.969

7.  A detailed molecular analysis of complete bovine leukemia virus genomes isolated from B-cell lymphosarcomas.

Authors:  Gonzalo Moratorio; Sabrina Fischer; Sergio Bianchi; Lorena Tomé; Gonzalo Rama; Gonzalo Obal; Federico Carrión; Otto Pritsch; Juan Cristina
Journal:  Vet Res       Date:  2013-03-18       Impact factor: 3.683

Review 8.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

9.  Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells.

Authors:  Jerome S Harms; Kurt A Eakle; Lillian S Kuo; Robert D Bremel; Gary A Splitter
Journal:  Genet Vaccines Ther       Date:  2004-08-24

10.  Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity.

Authors:  Véronique Goffin; Dominique Demonté; Caroline Vanhulle; Stéphane de Walque; Yvan de Launoit; Arsène Burny; Yves Collette; Carine Van Lint
Journal:  Nucleic Acids Res       Date:  2005-08-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.